Oral Misoprostol for Cervical Priming Before Hysteroscopy

• Register: ClinicalTrials.gov
• Last refreshed on: 19 February 2015
• Main ID: NCT02159911
• Date of registration: 02/06/2014
• Prospective Registration: No
• Primary sponsor: Saint-Joseph University
• Public title: Oral Misoprostol for Cervical Priming Before Hysteroscopy
• Scientific title: Use of Oral Misoprostol for Cervical Priming Before Hysteroscopy: a Randomized Comparison of Two Dosages
• Date of first enrolment: June 2004
• Target sample size: 84
• Recruitment status: Completed
• URL: http://clinicaltrials.gov/show/NCT02159911
• Study type: Observational
• Study design: Observational Model: Case Control, Time Perspective: Prospective
• Phase: N/A

Countries of recruitment

Lebanon

Contacts

• Name: Assaad K Kesrouani, MD
• Affiliation: Saint-Joseph University

Key inclusion & exclusion criteria

Inclusion Criteria:

- non pregnant patients

- considered medically fit without any life threatening conditions

- scheduled for operative hysteroscopy, regardless of age or indication of the
hysteroscopy

Exclusion Criteria:

- a positive history of vascular or coronary artery disease

- using other products that could affect the consistency of the cervix such as local
estrogen or laminaire



Age minimum: N/A
Age maximum: N/A
Gender: Female

Health Condition(s) or Problem(s) studied

Cervical Laceration

Adverse Effects

Intervention(s)

Drug: Misoprostol administered orally one hour before surgery

Primary Outcome(s)

Ease of cervical dilatation [Time Frame: Assessed during the surgery and recorded immediately at the end of surgery]

Secondary Outcome(s)

Adverse effects [Time Frame: recorded till 6 h following surgery]

Secondary ID(s)

USJ-002

Source(s) of Monetary Support

Please refer to primary and secondary sponsors